Table 2 Table with the statistics of the T2 values from all the patients per region of interest (ROI). The ROIs correspond to normal white matter (nWM), T2-hyperintensity (T2h), T1w-enhancement (T1e) and perilesional area (PER). Column 3: Mean over patients of the T2 ROI statistics. Column 4: 95% CI of the mean over patients of the T2 ROI statistics. Column 5: P-values of the Wilcoxon signed-rank test with the nWM (P-val ROI vs. nWM). Column 6: P-values of the Wilcoxon signed-rank test with the abnormal tissue without T1w-enhancement (P-val ROI vs. T2h). Column 7: P-values of the Wilcoxon signed-rank test with the T1w-enhancement voxels (P-val ROI vs. T1e).

From: Pre-contrast MAGiC in treated gliomas: a pilot study of quantitative MRI

ROI

ROI statistic

Mean (ms)

95% CI (ms)

Pval (ROI vs. nWM)

Pval (ROI vs. T2h)

Pval (ROI vs. T1e)

nWM

Mean

92.33

 ± 4.43

–

 < 0.01*

0.02*

SD

48.90

 ± 10.61

–

0.04*

0.02*

Skewness

10.72

 ± 1.75

–

 < 0.01*

0.02*

Kurtosis

184.88

 ± 57.84

–

 < 0.01*

0.02*

T2h

Mean

152.25

 ± 16.06

 < 0.01*

–

0.30

SD

64.63

 ± 12.34

0.04*

–

0.02*

Skewness

4.62

 ± 1.13

 < 0.01*

–

0.08

Kurtosis

42.38

 ± 13.60

 < 0.01*

–

0.08

T1e

Mean

180.05

 ± 22.52

0.02*

0.30

–

SD

130.81

 ± 45.67

0.02*

0.02*

–

Skewness

3.57

 ± 0.95

0.02*

0.08

–

Kurtosis

24.92

 ± 11.51

0.02*

0.08

–

PER

Mean

103.82

 ± 9.75

 < 0.01*

 < 0.01*

0.02*

SD

63.56

 ± 24.05

0.01*

0.50

0.16

Skewness

8.10

 ± 1.99

 < 0.01*

 < 0.01*

0.03*

Kurtosis

111.55

 ± 54.74

 < 0.01*

 < 0.01*

0.03*

  1. * indicates p < 0.05.
Back to article page